Snakebites inflicted by the arboreal viperid snake Bothriechis schlegelii in humans are characterized by pain, edema, and ecchymosis at the site of the bite, rarely with blisters, local necrosis, or defibrination. Herein, a comparative study of Bothriechis schlegelii snake venoms from Colombia (BsCo) and Costa Rica (BsCR) was carried out in order to compare their main activities and to verify the efficacy of Bothrops antivenom produced in Brazil to neutralize them. Biochemical (SDS-PAGE and zymography) and biological parameters (edematogenic, lethal, hemorrhagic, nociceptive, and phospholipase A2 activities) induced by BsCo and BsCR snake venoms were evaluated. The presence of antibodies in Bothrops antivenom that recognize BsCo and BsCR snake venoms by enzyme-linked immunosorbent assay and Western blotting, as well as the ability of this antivenom to neutralize the toxic activities were also verified. SDS-PAGE showed differences between venoms. Distinctive caseinolytic and hyaluronidase patterns were detected by zymography. BsCo and BsCR showed similar phospholipase A2 activity. Strong cross-reactivity between BsCo and BsCR was detected using Bothrops antivenom with many components located between 150 and 35 kDa. BsCR was more edematogenic and almost fourfold more hemorrhagic than BsCo, and both venoms induced nociception. BsCR (LD50 5.60 mg/kg) was more lethal to mice than BsCo (LD50 9.24 mg/kg). Bothrops antivenom was effective in the neutralization of lethal and hemorrhagic activities of BsCo and BsCR and was partially effective in the neutralization of edematogenic and nociceptive activities. In conclusion, geographic distribution influences the composition and activities of Bothriechis schlegelii venoms. Bothrops antivenom cross-reacted with these venoms and was partially effective in neutralizing some toxic activities of BsCo and BsCR.
ChippauxJP. Snake-bites: appraisal of the global situation. Bull World Health Organ1998; 76: 515–24.
2.
KasturiratneAWickremasingheARDe SilvaNGunawardenaNKPathmeswaranAPremaratnaRSavioliLLallooDGDe SilvaHJ. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PloS Med2008; 5: 1591–604.
3.
World Health Organization (WHO). Guidelines for the production, control and regulation of antivenom immunoglobulins, Geneva: WHO, 2010.
4.
GutiérrezJMTheakstonRDGWarrellDA. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PloS Med2006; 3: 727–31.
5.
WarrellDA. Snake bite. Lancet2010; 375: 77–88.
6.
GutiérrezJMLeónGBurnoufT. Antivenoms for the treatment of snakebite envenomings: the road ahead. Biologicals2011; 39: 129–42.
7.
OteroRGutiérrezJMesaMBDuqueERodríguezOArangoJLGómezFToroACanoFRodríguezLMCaroEMartínezJCornejoWGómezLMUribeFLCárdenasSNúñezVDíazA. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon2002; 40: 1107–14.
8.
CampbellJALamarWW. The venomous reptiles of the western hemisphere, Ithaca, NY: Comstock Publishing Associates, 2004, pp. p. 870–p. 870.
9.
WarrellDASnakebites in Central and South America: epidemiology, clinical features, and clinical management. In: CampbellJALamarWW (eds). The venomous reptiles of the western hemisphere, Ithaca, NY: Comstock Publishing Associates, 2004, pp. 709–61.
10.
OteroROsorioRGValderramaRGiraldoCA. Efectos farmacológicos y enzimáticos de los venenos de serpientes de Antioquia y Chocó (Colombia). Toxicon1992; 30: 611–20.
11.
OteroREnvenenamiento Ofídico. In: CorreaJAGómezJFPosadaR (eds). Fundamentos de Pediatría, Tomo V, Urgencias, Neurología, Otorrinolaringología, Ortopedia, Medellín: Corporación para Investigaciones Biológicas (CIB), 2014, pp. 73–119.
12.
PérezAVSaraviaPRucavadoASant’AnaCDSoaresAMGutiérrezJM. Local and systemic pathophysiological alterations induced by a serine proteinase from the venom of the snake Bothrops jararacussu. Toxicon2007; 49: 1063–9.
13.
StábeliRGSant’AnaCDRibeiroPHCostaTRTicliFKPiresMGNomizoAAlbuquerqueSMalta-NetoNRMarinsMSampaioSVSoaresAM. Cytotoxic L-amino acid oxidase from Bothrops moojeni: biochemical and functional characterization. Int J Biol Macromol2007; 41: 132–40.
14.
LomonteBEscolanoJFernándezJSanzLAnguloYGutiérrezJMCalveteJJ. Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii. J Prot Res2008; 7: 2445–57.
15.
ZycharBCDaleCSDemarchiDSGonçalvesLR. Contribution of metalloproteases, serine proteases and phospholipases A2 to the inflammatory reaction induced by Bothrops jararaca crude venom in mice. Toxicon2010; 55: 227–34.
16.
AnguloYChavesEAlapeARucavadoAGutiérrezJMLomonteB. Isolation and characterization of a myotoxic phospholipase A2 from the venom of the arboreal snake Bothriechis schlegelii from Costa Rica. Arch Biochem Biophys1997; 339: 260–6.
17.
FernándezJLomonteBSanzLAnguloYGutiérrezJMCalveteJJ. Snake venomics of Bothriechis nigroviridis reveals extreme variability among palm pitviper venoms: different evolutionary solutions for the same trophic purpose. J Proteome Res2010; 9: 4234–41.
18.
LomonteBTsaiWCBonillaFSolorzanoASolanoGÂnguloYGutiérrezJMCalveteJJ. Snake venomics and toxicological profiling of the arboreal pitviper Bothriechis supraciliaris from Costa Rica. Toxicon2012; 59: 592–9.
19.
GutiérrezJMLomonteBSanzLCalveteJJPlaD. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. J Proteomics2014; 105: 340–50.
20.
MuñozLJVEstrada-GomezSNúñezVSanzLCalveteJJ. Characterization and cDNA sequence of Bothriechis schlegelii-amino acid oxidase with antibacterial activity. Int J Biol Macromol2014; 69: 200–7.
21.
ChippauxJPWilliamsVWhiteJ. Snake venom variability: methods of study, results and interpretation. Toxicon1991; 29: 1279–303.
22.
Moura-da-SilvaAMDella-CasaMSDavidASAssakuraMTButeraDLebrunIShannonJDSerranoSMTFoxJW. Evidence for heterogeneous forms of the snake venom metalloproteinase Jararhagin: a factor contributing to snake venom variability. Arch Biochem Biophys2003; 409: 395–401.
23.
FurtadoMFDTravaglia-CardosoSRRochaMMT. Sexual dimorphism in venom of Bothrops jararaca (Serpentes: Viperidae). Toxicon2006; 48: 401–10.
24.
MenezesMCFurtadoMFTravaglia-CardosoSRCamargoACMSerranoSMT. Sex-based individual variation of snake venom proteome among eighteen Bothrops jararaca siblings. Toxicon2006; 47: 304–12.
25.
AntunesTCYamashitaKMBarbaroKCSaikiMSantoroML. Comparative analysis of newborn and adult Bothrops jararaca snake venoms. Toxicon2010; 56: 1443–58.
26.
ZelanisATashimaAKRochaMMTFurtadoMFDCamargoACMHoPLSerranoSMT. Analysis of the ontogenetic variation in the venom proteome/peptidome of Bothrops jararaca reveals different strategies to deal with prey. J Prot Res2010; 9: 2278–91.
27.
SantoroMLdo CarmoTCunhaBHAlvesAFZelanisASerranoSMGregoKFSant’AnnaSSBarbaroKCFernandesW. Ontogenetic Variation in Biological Activities of Venoms from Hybrids between Bothrops erythromelas and Bothrops neuwiedi Snakes. PLoS One2015; 10: e0145516–e0145516.
28.
GutiérrezJMHigashiHGWenFHBurnoufT. Strengthening antivenom production in Central and South American public laboratories: report of a workshop. Toxicon2007; 49: 30–5.
29.
OteroRGutiérrezJMRojasGNúñezVDíazAMirandaEUribeAFSilvaJFOspinaJGMedinaYToroMFGarcíaMELeónGGarcíaMLizanoSDe La TorreJMárquezJMenaYGonzálezNArenasLCPuzónABlancoNSierraAEspinalMEArboledaMJiménezJCRamírezPDíazMGuzmánMCBarrosJHenaoSRamírezAMaceaULozanoR. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon1999; 37: 895–908.
30.
BogarínGMoraisJFYamaguchiIKStephanoMAMarcelinoJRNishikawaAKGuidolinRRojasGHigashiHGGutiérrezJM. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon2000; 38: 1429–41.
31.
SchierJGWienerSWTougerMNelsonLSHoffmanRS. Efficacy of crotalidae polyvalent antivenin for treatment of hognosed viper (Porthidium nasutum) envenomation. Ann Emerg Med2003; 41: 391–5.
32.
LiraMSFurtadoMFMartinsLMPLopes-FerreiraMSantoroMLBarbaroKC. Enzymatic and immunochemical characterization of Bothrops insularis venom and its neutralization by polyspecific Bothrops antivenom. Toxicon2007; 49: 982–94.
33.
SeguraACastilloMCNúñezVYarlequéAGonçalvesLRVillaltaMBonillaCHerreraMVargasMFernándezMYanoMYAraújoHPBollerMALeónPTintayaBSano-MartinsISGómezAFernándezGPGeogheganPHigashiHGLeónGGutiérrezJM. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon2010; 56: 980–9.
34.
OteroRTobónGSGómezLFOsorioRGValderramaRHoyosDUrretaJEMolinaSArboledaJJ. Accidente ofídico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990). Acta Med Colomb1992; 17: 229–49.
35.
RawIGuidolinRHigashiHGKelenEMAAntivenins in Brazil: preparation. In: TuAT (eds). Handbook of natural toxins, vol 5, reptile venoms and toxins, New York: Marcel Dekker, 1991, pp. 557–81.
36.
SmithPKKrohnRIHermansonGTMalliaAKGartnerFHProvenzanoMDFujimotoEKGoekeNMOlsonBJKlenkDC. Measurement of protein using bicinchoninic acid. Anal Biochem1985; 150: 76–85.
37.
LaemmliUK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature1970; 227: 680–5.
38.
BlumHBeierHGrossHJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Eletrophoresis1987; 8: 93–9.
39.
TowbinHStaehelinTGordonJ. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A1979; 76: 4350–4.
40.
MiuraROYamagataSMiuraYHaradaTYamagataT. Analysis of glycosaminoglycan-degrading enzymes by substrate gel electrophoresis (Zymography). Anal Biochem1995; 225: 333–40.
41.
BarbaroKCKnysakIMartinsRHoganCWinkelK. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon2005; 45: 489–99.
42.
KondoHKondoSIkezawaIMurataROhsakaA. Studies of the quantitative method for determination of hemorrhagic activity of habu snake venom. Jpn J Med Sci Bio1960; 13: 43–51.
43.
GutiérrezJMGenéJARojasGCerdasL. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon1985; 23: 887–93.
44.
HunskaarSFasmerOBHoleK. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Meth1985; 14: 69–76.
45.
LitchfieldJTWilcoxonF. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther1949; 96: 99–113.
46.
MaltaMBLiraMSSoaresSLRochaGCKnysakIMartinsRGuizzeSPSantoroMLBarbaroKC. Toxic activities of Brazilian centipede venoms. Toxicon2008; 52: 255–63.
47.
GenéJAGómezMGutiérrezJMCerdasL. Neutralization of hyaluronidase and indirect hemolytic activities of Costa Rica snake venoms by a polyvalent antivenom. Toxicon1985; 23: 1015–8.
48.
KuchUMebsDGutiérrezJMFreireA. Biochemical and biological characterization of Ecuadorian pitviper venoms (genera Bothriechis, Bothriopsis, Bothrops and Lachesis). Toxicon1996; 34: 714–7.
49.
BolañosR. Toxicity of Costa Rican snake venoms for the white mouse. Am J Trop Med Hyg1972; 21: 360–3.
50.
DaltryJCWüsterWThorpeRS. Diet and snake venom evolution. Nature1996; 379: 537–40.
51.
FerreiraMLMoura-da-SilvaAMMotaI. Neutralization of different activities of venoms from nine species of Bothrops snakes by Bothrops jararaca antivenom. Toxicon1992; 30: 1591–602.
52.
QueirózGPPessoaLAPortaroFCVFurtadoMFDTambourgiDV. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus. Toxicon2008; 52: 842–51.
53.
FurtadoMFDCardosoSTSoaresOEPereiraAPFernandesDSTambourgiDVSant’annaOA. Antigenic cross-reactivity and immunogenicity of Bothrops venoms from snakes of the Amazon region. Toxicon2010; 55: 881–7.
54.
SeguraACastilloMCNúñezVYarlequéAGonçalvesLRCVillaltaMBonillaCHerreraMVargasMFernándezMYanoMYAraújoHPBollerMAALeónPTintayaBSano-MartinsISGómezAFernándezGPGeogheganPHigashiHGLeónGGutiérrezJM. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon2010; 56: 980–9.
